Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: BMJ Publishing Group 2021-10-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/10/e003149corr1.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849765100572901376
collection DOAJ
format Article
id doaj-art-3269e151e26c4d79a323c080faac7c2c
institution DOAJ
issn 2051-1426
language English
publishDate 2021-10-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-3269e151e26c4d79a323c080faac7c2c2025-08-20T03:04:58ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-10-0191010.1136/jitc-2021-003149corr1Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct designhttps://jitc.bmj.com/content/9/10/e003149corr1.full
spellingShingle Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
Journal for ImmunoTherapy of Cancer
title Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
title_full Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
title_fullStr Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
title_full_unstemmed Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
title_short Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
title_sort correction systematic preclinical evaluation of cd33 directed chimeric antigen receptor t cell immunotherapy for acute myeloid leukemia defines optimized construct design
url https://jitc.bmj.com/content/9/10/e003149corr1.full